Small_1998_Am.J.Med_104_39S

Reference

Title : Treatment of Alzheimer's disease: current approaches and promising developments - Small_1998_Am.J.Med_104_39S
Author(s) : Small GW
Ref : American Journal of Medicine , 104 :39S , 1998
Abstract :

Alzheimer's disease (AD) is characterized by a gradual decline in 3 domains: cognition, behavior, and function. Ideally, an effective treatment would target all 3 types of impairment. However, available treatments for AD diminish only certain symptoms and cannot halt the dementing process. Most pharmacologic agents currently available or in development target a specific symptom cluster (e.g., cognitive loss), and are based on the known neurobiology of the disease (e.g., neurotransmitter deficit) or hypothesized antidementia approaches (e.g., anti-inflammation, antioxidation). Two currently available cholinesterase inhibitors improve memory and other aspects of cognition during short-term treatment. Additional cholinergic agents will soon become available. Other promising agents under study for cognitive enhancement or protection include vitamin E, selegiline, estrogen, and nonsteroidal anti-inflammatory drugs. As scientists uncover the basic pathogenetic mechanisms of AD, additional treatments will likely emerge. Therapies for behaviors associated with dementia (e.g., depression, agitation, anxiety) are sometimes effective. Choices of specific medications, including antidepressants, antipsychotics, and anxiolytics, depend on specific side-effect profiles. Psychotherapies aimed at enhancing cognition are ineffective for dementia but nonpharmacologic interventions may minimize depression and agitation and may improve quality of life.

PubMedSearch : Small_1998_Am.J.Med_104_39S
PubMedID: 9617851

Related information

Citations formats

Small GW (1998)
Treatment of Alzheimer's disease: current approaches and promising developments
American Journal of Medicine 104 :39S

Small GW (1998)
American Journal of Medicine 104 :39S